Lonza invests $418m in two biomanufacturing solutions
Lonza announced it would invest in two new “Ibex Solutions”, which offer manufacturing capabilities to biotechs developing antibody therapies.
Archives for September 21, 2018
TriLink BioTechnologies to relocate to expand operations
TriLink BioTechnologies, a subsidiary of Maravai, that provides gene therapy services to researchers, has announced it will relocate to expand the company’s operations.
Novartis ‘disappointed’ and ‘surprised’ by NICE CAR-T call
NICE has deemed Novartis’ CAR T-cell therapy Kymriah too expensive for the UK market.